XML 32 R18.htm IDEA: XBRL DOCUMENT
v3.22.2.2

Revenue | 9 Months Ended
--- | ---
Sep. 30, 2022
Revenue From Contract With Customer [Abstract] |
Revenue | (12) Revenue We recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which we expect to be entitled in exchange for those goods or services. Our estimate for amounts not expected to be collected based on historical experience will continue to be recognized as a reduction to net revenue. However, subsequent changes in estimate of collectability due to a change in the financial status of a payer, for example a bankruptcy, will be recognized as bad debt expense in operating charges. The performance obligation is separately identifiable from other promises in the customer contract. As the performance obligations are met (i.e.: room, board, ancillary services, level of care), revenue is recognized based upon allocated transaction price. The transaction price is allocated to separate performance obligations based upon the relative standalone selling price. In instances where we determine there are multiple performance obligations across multiple months, the transaction price will be allocated by applying an estimated implicit and explicit rate to gross charges based on the separate performance obligations. In assessing collectability, we have elected the portfolio approach. This portfolio approach is being used as we have large volume of similar contracts with similar classes of customers. We reasonably expect that the effect of applying a portfolio approach to a group of contracts would not differ materially from considering each contract separately. Management’s judgment to group the contracts by portfolio is based on the payment behavior expected in each portfolio category. As a result, aggregating all of the contracts (which are at the patient level) by the particular payer or group of payers, will result in the recognition of the same amount of revenue as applying the analysis at the individual patient level. We group our revenues into categories based on payment behaviors. Each component has its own reimbursement structure which allows us to disaggregate the revenue into categories that share the nature and timing of payments. The other patient revenue consists primarily of self-pay, government-funded non-Medicaid, and other. The following table disaggregates our revenue by major source for the three and nine-month periods ended September 30, 2022 and 2021 (in thousands):
| For the three months ended September 30, 2022 |
| Acute Care |  |  | Behavioral Health |  |  | Other |  |  | Total |
Medicare | $ | 314,785 |  |  | 16 | % |  | $ | 86,125 |  |  | 6 | % |  |  |  |  |  | $ | 400,910 |  |  | 12 | %
Managed Medicare |  | 305,239 |  |  | 16 | % |  |  | 78,554 |  |  | 5 | % |  |  |  |  |  |  | 383,793 |  |  | 12 | %
Medicaid |  | 200,656 |  |  | 10 | % |  |  | 195,656 |  |  | 14 | % |  |  |  |  |  |  | 396,312 |  |  | 12 | %
Managed Medicaid |  | 213,723 |  |  | 11 | % |  |  | 373,456 |  |  | 26 | % |  |  |  |  |  |  | 587,179 |  |  | 18 | %
Managed Care (HMO and PPOs) |  | 631,670 |  |  | 33 | % |  |  | 363,442 |  |  | 25 | % |  |  |  |  |  |  | 995,112 |  |  | 30 | %
UK Revenue |  | 0 |  |  | 0 | % |  |  | 166,843 |  |  | 12 | % |  |  |  |  |  |  | 166,843 |  |  | 5 | %
Other patient revenue and adjustments, net |  | 38,427 |  |  | 2 | % |  |  | 115,969 |  |  | 8 | % |  |  |  |  |  |  | 154,396 |  |  | 5 | %
Other non-patient revenue |  | 215,178 |  |  | 11 | % |  |  | 54,783 |  |  | 4 | % |  |  | (18,479 | ) |  |  | 251,482 |  |  | 8 | %
Total Net Revenue | $ | 1,919,678 |  |  | 100 | % |  | $ | 1,434,828 |  |  | 100 | % |  | $ | (18,479 | ) |  |  | 3,336,027 |  |  | 100 | %
| For the nine months ended September 30, 2022 |
| Acute Care |  |  | Behavioral Health |  |  | Other |  |  | Total |
Medicare | $ | 970,060 |  |  | 17 | % |  | $ | 248,987 |  |  | 6 | % |  |  |  |  |  | $ | 1,219,047 |  |  | 12 | %
Managed Medicare |  | 944,072 |  |  | 17 | % |  |  | 213,281 |  |  | 5 | % |  |  |  |  |  |  | 1,157,353 |  |  | 12 | %
Medicaid |  | 540,590 |  |  | 9 | % |  |  | 554,970 |  |  | 13 | % |  |  |  |  |  |  | 1,095,560 |  |  | 11 | %
Managed Medicaid |  | 547,452 |  |  | 10 | % |  |  | 1,071,792 |  |  | 25 | % |  |  |  |  |  |  | 1,619,244 |  |  | 16 | %
Managed Care (HMO and PPOs) |  | 1,898,040 |  |  | 33 | % |  |  | 1,104,658 |  |  | 26 | % |  |  |  |  |  |  | 3,002,698 |  |  | 30 | %
UK Revenue |  | 0 |  |  | 0 | % |  |  | 516,166 |  |  | 12 | % |  |  |  |  |  |  | 516,166 |  |  | 5 | %
Other patient revenue and adjustments, net |  | 204,660 |  |  | 4 | % |  |  | 362,697 |  |  | 9 | % |  |  |  |  |  |  | 567,357 |  |  | 6 | %
Other non-patient revenue |  | 602,636 |  |  | 11 | % |  |  | 162,664 |  |  | 4 | % |  |  | 9,665 |  |  |  | 774,965 |  |  | 8 | %
Total Net Revenue | $ | 5,707,510 |  |  | 100 | % |  | $ | 4,235,215 |  |  | 100 | % |  | $ | 9,665 |  |  | $ | 9,952,390 |  |  | 100 | %
| For the three months ended September 30, 2021 |
| Acute Care |  |  | Behavioral Health |  |  | Other |  |  | Total |
Medicare | $ | 310,483 |  |  | 17 | % |  | $ | 96,219 |  |  | 7 | % |  |  |  |  |  | $ | 406,702 |  |  | 13 | %
Managed Medicare |  | 280,674 |  |  | 15 | % |  |  | 66,249 |  |  | 5 | % |  |  |  |  |  |  | 346,923 |  |  | 11 | %
Medicaid |  | 136,989 |  |  | 8 | % |  |  | 146,281 |  |  | 11 | % |  |  |  |  |  |  | 283,270 |  |  | 9 | %
Managed Medicaid |  | 176,497 |  |  | 10 | % |  |  | 326,789 |  |  | 25 | % |  |  |  |  |  |  | 503,286 |  |  | 16 | %
Managed Care (HMO and PPOs) |  | 674,396 |  |  | 37 | % |  |  | 349,275 |  |  | 26 | % |  |  |  |  |  |  | 1,023,671 |  |  | 32 | %
UK Revenue |  | 0 |  |  | 0 | % |  |  | 173,728 |  |  | 13 | % |  |  |  |  |  |  | 173,728 |  |  | 6 | %
Other patient revenue and adjustments, net |  | 69,935 |  |  | 4 | % |  |  | 117,442 |  |  | 9 | % |  |  |  |  |  |  | 187,377 |  |  | 6 | %
Other non-patient revenue |  | 173,053 |  |  | 9 | % |  |  | 52,310 |  |  | 4 | % |  |  | 5,679 |  |  |  | 231,042 |  |  | 7 | %
Total Net Revenue | $ | 1,822,027 |  |  | 100 | % |  | $ | 1,328,293 |  |  | 100 | % |  | $ | 5,679 |  |  | $ | 3,155,999 |  |  | 100 | %
| For the nine months ended September 30, 2021 |
| Acute Care |  |  | Behavioral Health |  |  | Other |  |  | Total |
Medicare | $ | 954,207 |  |  | 18 | % |  | $ | 277,438 |  |  | 7 | % |  |  |  |  |  | $ | 1,231,645 |  |  | 13 | %
Managed Medicare |  | 830,627 |  |  | 16 | % |  |  | 185,323 |  |  | 5 | % |  |  |  |  |  |  | 1,015,950 |  |  | 11 | %
Medicaid |  | 418,335 |  |  | 8 | % |  |  | 526,945 |  |  | 13 | % |  |  |  |  |  |  | 945,280 |  |  | 10 | %
Managed Medicaid |  | 473,256 |  |  | 9 | % |  |  | 995,749 |  |  | 24 | % |  |  |  |  |  |  | 1,469,005 |  |  | 16 | %
Managed Care (HMO and PPOs) |  | 1,862,012 |  |  | 35 | % |  |  | 1,070,165 |  |  | 26 | % |  |  |  |  |  |  | 2,932,177 |  |  | 31 | %
UK Revenue |  | 0 |  |  | 0 | % |  |  | 510,614 |  |  | 13 | % |  |  |  |  |  |  | 510,614 |  |  | 5 | %
Other patient revenue and adjustments, net |  | 248,342 |  |  | 5 | % |  |  | 366,669 |  |  | 9 | % |  |  |  |  |  |  | 615,011 |  |  | 7 | %
Other non-patient revenue |  | 484,221 |  |  | 9 | % |  |  | 142,224 |  |  | 3 | % |  |  | 20,739 |  |  |  | 647,184 |  |  | 7 | %
Total Net Revenue | $ | 5,271,000 |  |  | 100 | % |  | $ | 4,075,127 |  |  | 100 | % |  | $ | 20,739 |  |  | $ | 9,366,866 |  |  | 100 | %

X
- References No definition available. + Details
Name: | us-gaap_RevenueFromContractWithCustomerAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -URI https://asc.fasb.org/topic&trid=49130388 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 10 -URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 13 -Subparagraph (b)(2) -URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 12 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 9 -URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130550-203045 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 12 -Subparagraph (e) -URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 12 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 12 -Subparagraph (d) -URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 15 -URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130558-203045 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 12 -Subparagraph (c) -URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045 + Details
Name: | us-gaap_RevenueFromContractWithCustomerTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration